Blog
Liz Ann Sonders Talks About Stock Prices, the Labor Market, Economic Cycles, and More
In this podcast, Motley Fool senior analyst John Rotonti talks with Liz Ann Sonders, chief investment strategist at Charles Schwab, about topics including:
To catch full episodes of all The Motley
Consumer Goods Stocks to Watch
In this podcast, Motley Fool senior analyst Bill Mann discusses:
Motley Fool host Alison Southwick and Motley Fool personal finance expert Robert Brokamp talk with Motley Fool senior analyst Emily
3 Red Flags for Block's Future
Block's (NYSE: SQ) stock plunged nearly 80% over the past 12 months as the fintech giant disappointed investors with its dismal growth rates. Rising interest rates exacerbated the pain by crushing
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
The artificial intelligence (AI) market has become one of the tech sector's hottest pockets of growth in recent years. Many organizations now realize that crunching massive amounts of data with AI
3 Top Stocks to Buy for the Long Haul
The best way to build wealth is to buy many stocks and hold them for the long haul. That way, you can ride out the market's short-term volatility and benefit from the value created by great
This Stock Is Your Ticket to an $80 Trillion Market Opportunity
While there's currently a lot of uncertainty about the near-term direction of the global economy, the long-term outlook is crystal clear. The economy is on track to keep expanding in the decades
Better Buy: Carnival Cruise vs. Royal Caribbean Stock
The cruise line industry has seen some unprecedented twists and turns over the last few years, but it's started to rebound now that pandemic-related headwinds have lessened. Carnival (NYSE: CCL) and
Here's How Starbucks' Rebound Plan Might Go Wrong
Starbucks (NASDAQ: SBUX) has a new rebound plan. Just a few months after outgoing CEO Howard Schultz said that management had some ideas to "reinvent the company," investors now have clarity on
1 Beaten-Down Nasdaq Stock That Could Soar 55% to 146%, According to Wall Street
Semiconductor giant Nvidia (NASDAQ: NVDA) may be having a tough time on the stock market this year, but that hasn't deterred Wall Street analysts from being upbeat about the chipmaker's prospects.
Better Dividend Buy: Chevron or Enterprise Products Partners?
Oil and natural gas prices have recovered strongly from their most recent nadir in 2020. Now is the perfect time to consider the risk that a new drawdown could be in the cards in this highly
Why I Own Texas Instruments Stock
Motley Fool contributor Jason Hall breaks down Texas Instruments (NASDAQ: TXN) stock. Although many people know Texas Instruments for its calculators, its analog semiconductor business is the real
Social Security: How to Boost Your Benefits by $10,848 Per Year
Social Security is an integral source of income for millions of retirees, and 76% of U.S. adults say that it's more important than ever to optimize their benefits, according to a 2022 survey from
Mortgage Rates Are the Highest Since 2008: 3 Companies to Avoid
Mortgage rates are moving higher. According to Freddie Mac, 30-year mortgage rates surpassed 6% for the first time since 2008 and are moving directly due to the Federal Reserve's fight against
Peloton's Big Bet, Revealed in 1 Chart
Even if you don't keep tabs on every up-and-coming company, you likely know of Peloton Interactive (NASDAQ: PTON) as the fitness equipment outfit that surged in popularity during the pandemic. Its
Missed Out on Nvidia? My Best Chip Stock to Buy and Hold
Nvidia (NASDAQ: NVDA) emerged as one of the more notable semiconductor growth stories over the last few years. Once just a gaming chip company, it has successfully repurposed its technology to the
If You Invested $3,000 in Atlassian Stock in 2015, This Is How Much You Would Have Today
Atlassian (NASDAQ: TEAM) has generated massive gains for its early investors since its initial public offering (IPO) on Dec. 10, 2015. The Australian software company listed its shares at $21, which
Want $500 in Passive Income? Invest $10,000 in These 3 Warren Buffett Dividend Stocks and Wait 3 Years
Thousands of words have been dedicated to explaining Warren Buffett's investment strategy over the years, both by the legendary investor himself and others. All of that, however, can be boiled down
Want More Income? Invest Your Money Here
You've undoubtedly heard the old saying: "It takes money to make money." While there are some ways to generate income without investing money, those either take a lot of time or require taking on
2 High-Yield Dividend Stocks You Could Hold for Years
Here's a sobering statistic for investors to chew on: Almost 90% of the Fortune 500 companies from 1955 have gone bankrupt, merged, were acquired, or faded into obscurity and were removed from the
3 Social Security Changes That Could Benefit Seniors Big Time
Although Social Security has been around for many years, its rules are not set in stone. From time to time, bigger changes can come down the pike that work to seniors' advantage. Here are three such
Is Now the Time to Buy Cardano?
Now that The Merge from Ethereum has been completed, it's time for investors to turn their attention to the other big technological upgrade for the crypto community: the Vasil hard fork from Cardano
Have $5,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
In the wake of the market's 2022 sell-off, many companies have reached valuations that interest me. However, these aren't stocks I'm interested in buying to make a quick buck. Instead, these are
2 Big Winners in the Navy's $64 Billion Destroyer Program
DDG(X) is dead. Long live DDG(X)!
It's been nearly three decades since the U.S. Navy first began considering a plan to replace and update its fleet of DDG-51 Arleigh Burke-class guided missile
3 Growth Stocks Down 53% to 83% to Buy Now, According to Wall Street
The bears have a firm grip on the technology sector in 2022, and that grip tightened this week when the U.S. Federal Reserve adopted an interest rate policy that was more aggressive than expected
Is AbbVie a Buy?
Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. It pays a reasonably high dividend yield and has products in a wide range


